全文获取类型
收费全文 | 218篇 |
免费 | 28篇 |
国内免费 | 12篇 |
专业分类
儿科学 | 5篇 |
妇产科学 | 6篇 |
基础医学 | 41篇 |
临床医学 | 15篇 |
内科学 | 89篇 |
皮肤病学 | 4篇 |
特种医学 | 4篇 |
外科学 | 1篇 |
综合类 | 25篇 |
预防医学 | 61篇 |
眼科学 | 1篇 |
药学 | 3篇 |
肿瘤学 | 3篇 |
出版年
2023年 | 1篇 |
2022年 | 12篇 |
2021年 | 10篇 |
2020年 | 13篇 |
2019年 | 8篇 |
2018年 | 12篇 |
2017年 | 8篇 |
2016年 | 14篇 |
2015年 | 18篇 |
2014年 | 22篇 |
2013年 | 22篇 |
2012年 | 21篇 |
2011年 | 23篇 |
2010年 | 7篇 |
2009年 | 11篇 |
2008年 | 16篇 |
2007年 | 13篇 |
2006年 | 10篇 |
2005年 | 5篇 |
2004年 | 4篇 |
2003年 | 2篇 |
2001年 | 1篇 |
2000年 | 1篇 |
1998年 | 2篇 |
1997年 | 1篇 |
1993年 | 1篇 |
排序方式: 共有258条查询结果,搜索用时 984 毫秒
61.
《Journal of infection and chemotherapy》2020,26(5):523-526
Transmissible gastroenteritis virus (TGEV) and porcine epidemic diarrhea virus (PEDV) are the main pathogens causing viral diarrhea in pig, mixed infections of these two viruses are very common in intensive pig rearing. However, there is a lack of a method to simultaneously detect and distinguish PEDV and TGEV in preclinical levels. In this study, we aimed to establish a dual ultrasensitive nanoparticle DNA probe-based PCR assay (dual UNDP-PCR) based on functionalized magnetic bead enrichment and specific nano-technology amplification for simultaneous detection and distinguish diagnosis of PEDV and TGEV. The detection limit of dual UNDP-PCR for single or multiple infections of PEDV and TGEV is 25 copies/g, which is 400 times more sensitive than the currently known duplex RT-PCR, showing better specificity and sensitivity without cross-reaction with other viruses. For pre-clinical fecal samples, the dual UNDP-PCR showed a markedly higher positive detection rate (52.08%) than conventional duplex RT-PCR (13.21%), can rapidly and accurately identify targeted pathogens whenever simple virus infection or co-infection. In summary, this study provides a technique for detecting and distinguishing PEDV and TGEV in preclinical levels, which is high sensitivity, specificity, repeatability, low cost and broad application prospect. 相似文献
62.
Real-time Taqman PCR targeting 14 human papilloma virus types 总被引:1,自引:0,他引:1
Magnus Lindh Staffan Grander Elin Andersson Peter Horal Inger Mattsby-Balzer Walter Ryd 《Journal of clinical virology》2007,40(4):321-324
BACKGROUND: Subtyping of human papilloma virus (HPV) may enhance the precision of vaginal cytological assessments and will be important for investigating the effect of the recently introduced vaccine against types 16 and 18. OBJECTIVES AND STUDY DESIGN: To evaluate an in-house real-time PCR targeting HPV types 16-18-31-33-35-39-45-51-52-56-58-59-6-11, by analysing 107 liquid-based cytology specimens representing various degrees of dysplasia. RESULTS: In all, 71 samples were HPV positive, with multiple types present in 37 (52%). Comparison with Roche Linear Array on a subset of 24 of these 71 samples showed a good agreement. One or several types were detected in 17/17 (100%) samples with cervical intraepithelial neoplasia grade 2-3 (CIN 2-3), 16/19 (84%) with CIN 1, 32/43 (74%) with Atypical Squamous Cells of Undetermined Significance (ASCUS), and in 6/28 (21%) with benign cytology. Estimates of mean viral load were lower in CIN 1-3 than in ASCUS ( approximately 4000 vs. approximately 25,000 copies/1000 cells), and clearly lower in samples with benign cytology ( approximately 50 copies/1000 cells). CONCLUSION: The HPV rates in groups with different degrees of dysplasia agrees with previous reports and support a strong link between types 16/18 and severe dysplasia. The high rate of multiple type infection might influence the outcome of HPV vaccination. The possible importance of viral load should be further studied. 相似文献
63.
64.
65.
河北省某县有偿献血丙型肝炎病毒感染者血清抗-HIV检测分析 总被引:2,自引:0,他引:2
目的:调查并分析河北省某县有偿献血员中丙型肝炎病毒(HCV)感染者艾滋病病毒Ⅰ型(HIV-1)感染情况。方法:采用实时定量聚合酶链反应(PCR)和酶联免疫吸附试验(ELISA)法等检测了抗-HCV、HCV核糖核酸(RNA)和抗-HIV。结果:共检测109例受HCV感染的献血员,其中ALT异常者为38.53%(42/109),抗-HCV阳性率为95.41%(104/109),HCV RNA阳性率为70.64%(77/109),抗-HIV阳性率为0(0/109)。结论:在该县有偿献血HCV感染者中HIV-1感染率为0,HCV感染者中HIV-1感染存在地区差异,并非所有地区HCV感染者HIV感染率均高。 相似文献
66.
MacDonald DC Nelson M Bower M Powles T 《World journal of gastroenterology : WJG》2008,14(11):1657-1663
The incidence of hepatocellular carcinoma (HCC) in patients with human immunodeficiency virus (HIV) is rising. HCC in HIV almost invariably occurs in the context of hepatitis C virus (HCV) or hepatitis B virus (HBV) co-infection and, on account of shared modes of transmission, this occurs in more than 33% and 10% of patients with HIV worldwide respectively. It has yet to be clearly established whether HIV directly accelerates HCC pathogenesis or whether the rising incidence is an epiphenomenon of the highly active antiretroviral therapy (HAART) era, wherein the increased longevity of patients with HIV allows long-term complications of viral hepatitis and cirrhosis to develop. Answering this question will have implications for HCC surveillance and the timing of HCV/HBV therapy, which in HIV co-infection presents unique challenges. Once HCC develops, there is growing evidence that HIV co-infection should not preclude conventional therapeutic strategies, including liver transplantation. 相似文献
67.
目的通过比较HIV/HCV共感染与HCV单纯感染患者的肝组织病理学改变,研究HIV对HCV自然病程的影响,了解HIV在共感染者肝脏病理改变中所起的作用。方法选取HCV单纯感染者50例,HIV/HCV共感染者18例,在两组临床及实验室资料无显著性差异的情况下,对两组肝脏组织病理进行比较、分析。结果两组在炎症活动度(G)和纤维化程度(S)上均无明显差异(P>0.05)。但是HIV/HCV共感染组较HCV单纯感染组汇管区淋巴细胞明显减少(P<0.001),小叶内库普弗细胞增生较活跃(P<0.001),有明显统计学意义。而在汇管区胆管损伤和炎细胞浸润程度,小叶内炎症浸润程度及范围,有无纤维化和纤维化程度,有无脂肪变性和脂肪变性的程度及类型等多方面的比较中两组标本均无明显差异(P>0.05)。结论合并HIV感染并未明显改变HCV感染者的疾病进程,在其肝脏病理改变中仅使淋巴细胞明显减少,库普弗细胞增生活跃,对炎症活动度和纤维化程度均无明显影响。 相似文献
68.
BackgroundHepatitis B (HBV) reactivation in chronic hepatitis C (CHC) patients treated with IFN-free direct acting antiviral (DAA) therapies has recently emerged as a potential risk. Given the potential burden of this issue, further data are needed to establish its actual clinical impact.ObjectivesThe aim of the present study was to analyze the occurrence of HBV reactivation in a cohort of CHC patient treated with DAAs in routine clinical practice.Study designConsecutive CHC patients with different genotypes, treated with DAA between January 2015 and January 2016 were included in the study. Subjects had been tested for HBsAg and anti-HBc antibodies before antiviral therapy. HBV-DNA levels were examined in anti-HBc positive patients at baseline and 24 weeks after the end of treatment. Post-treatment HBsAg determination was performed in case of HBV-DNA positivity. Serum anti-HBs kinetics was analysed in anti-HBs and anti-HBc positive subjects.ResultsA cohort of 137 consecutive HCV patients treated with IFN-free regimens in routine clinical practice was evaluated. From this cohort, plasma samples of 44 subjects with positive serology for HBV (anti-HBc positive) were tested for HBV-DNA levels at baseline and 24 weeks after the end of treatment. Two of them were HBsAg-positive, while the others had signs of a past HBV exposure (HBsAg-negative ± HBsAb-positive). No reactivation was found in HBcAb-positive and HBsAg-negative subjects. In the two HBsAg-positive, one experienced an increase in HBV-DNA levels of ≥2 log10 IU/mL during treatment. However, the reactivation was without clinical impact and, most important, was followed by HBsAg loss.ConclusionsBased on our experience, a past HBV infection seems not to be a condition predisposing to HBV reactivation. On the contrary, in HBsAg-positive subjects not in suppressive treatment with nucleos(t)ide analogs, regular monitoring of HBV-DNA during and after DAA treatment should be considered. 相似文献
69.
Laksmi Wulandari Muhammad Amin Gatot Soegiarto Kenji Ishiwata 《The Indian journal of tuberculosis》2021,68(3):340-349
BackgroundTuberculosis is a chronic infection caused by Mycobacterium tuberculosis (M.tb), which needs proper macrophage activation for control. It has been debated whether the co-infection with helminth will affect the immune response to mycobacterial infection.ObjectiveTo determine the effect of sequential co-infection of Heligmosomoides polygyrus (H.pg) nematodes and M.tb on T cell responses, macrophages polarization and lung histopathological changes.MethodThis study used 49 mice divided into 7 treatment groups, with different sequence of infection of M.tb via inhalation and H.pg via oral ingestion for 8 and 16 weeks. T cells response in the lung, intestine, and peripheral blood were determined by flow cytometry. Cytokines (IL-4, IFN-γ, TGB-β1, and IL-10) were measured in peripheral blood using ELISA. Lung macrophage polarization were determined by the expression of iNOS (M1) or Arginase 1 (M2). Mycobacterial count were done in lung tissue. Lung histopathology were measured using Dorman’s semiquantitative score assessing peribronchiolitis, perivasculitis, alveolitis, and granuloma formation.ResultM.tb infection induced Th1 response and M1 macrophage polarization, while H.pg infection induced Th2 and M2 polarization. In sequential co-infection, the final polarization of macrophage was dictated by the sequence of co-infection. However, all groups with M.tb infection showed the same degree of mycobacterial count in lung tissues and lung tissue histopathological changes.ConclusionSequential co-infection of H.pg and M.tb induces different T cell response which leads to different macrophage polarization in lung tissue. Helminth infection induced M2 lung macrophage polarization, but did not cause different mycobacterial count nor lung histopathological changes. 相似文献
70.
Takamasa Kan Kosaku Komiya Kokoro Honjo Sonoe Uchida Akihiko Goto Hiroshi Kawano Shuichi Takikawa Tetsuyuki Yoshimatsu Jun-ichi Kadota 《Journal of infection and chemotherapy》2019,25(9):714-719
Whether or not additional antibiotics with anti-tuberculosis agents are required to treat bacterial co-infection with pulmonary tuberculosis is unclear. We aimed to assess the impact of additional antibiotics on mortality in pulmonary tuberculosis patients whose sputum cultures were positive for general bacteria as a surrogate definition of bacterial pneumonia. This study was a single-center retrospective cohort using a propensity score analysis. We included patients who were admitted for pulmonary tuberculosis and whose sputum cultures were positive for general bacteria. The mortality of patients who received additional antibiotics was analyzed after adjusting for other variables, including the propensity score predicting treatment with additional antibiotics. We assessed 68 and 55 tuberculosis patients treated with and without general antibiotics, respectively. Additional antibiotics tended to be administered to patients with a high level of C-reactive protein and neutrophil count, poor performance status, hypoxemia and hypoalbuminemia (C-statistics of area under receiver operating characteristic curve to the propensity score; 0.884, p < 0.001). In the multivariate analysis, advanced age and not the use of additional antibiotics was associated with in-hospital mortality. Additional antibiotics with anti-tuberculosis agents may not improve the prognosis of pulmonary tuberculosis patients whose sputum cultures were positive for general bacteria. Isolation of general bacteria does not equate to complication with bacterial pneumonia, so physicians should not administer general antibiotics to TB patients based solely on the results of sputum culture for general bacteria. A prospective study is needed to verify these results using a more accurate definition of pulmonary tuberculosis complicated with bacterial pneumonia. 相似文献